Related references
Note: Only part of the references are listed.Autoimmune Rheumatic Diseases 2 Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment
Grainne Murphy et al.
LANCET (2013)
Large-Scale Analysis of Tumor Necrosis Factor α Levels in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2012)
Elevated interleukin-32 expression in granulomatosis with polyangiitis
Suyoung Bae et al.
RHEUMATOLOGY (2012)
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis
Francesco Ciccia et al.
ARTHRITIS AND RHEUMATISM (2011)
Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis
Hirofumi Shoda et al.
ARTHRITIS RESEARCH & THERAPY (2011)
The role of innate immunity in autoimmune tissue injury
Ramanjaneyulu Allam et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Interleukin-32 induces the differentiation of monocytes into macrophage-like cells
Mihai G. Netea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus
Martin Aringer et al.
ARTHRITIS AND RHEUMATISM (2007)
The classification of glomerulonephritis in systemic lupus erythematosus revisited
JJ Weening et al.
KIDNEY INTERNATIONAL (2004)
Drug-induced systemic lupus erythematosus associated with etanercept therapy
N Shakoor et al.
LANCET (2002)
Share Paper
